LumiThera Inc.: LumiThera, Inc. Announces Completion of Diop

SEATTLE, March 3, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the

Related Keywords

United States , American , Clarke Tedford , Kostenloser Wertpapierhandel , Joe Fontanetta , Diopsys Inc , European Union , Food Drug Administration , Lumithera Inc , Prnewswire Lumithera Inc , Thera Inc , Delivery System , Age Related Macular Degeneration , South American , Visual Evoked Potential , Testing System , Light Delivery System , Valeda Light Delivery System , Drug Administration , Lumithera , Nnounces , Completion , Biopsys , Cquisition ,